Jazz Pharmaceuticals, Inc. JAZZ shares are soaring today, gaining more than 15% after the company reported earnings last night.
The company reported earnings that beat Wall Street estimates and raised 2011 earnings estimates. The company said it expects to earn $2.68 to $2.79 per share in 2011 on revenues of $247-$260 million. Wall Street is expecting earnings of $2.68 per share on revenues of $255 million.
Jazz Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes products for neurology and psychiatry primarily in the United States.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in